UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (5), p.2351-2359

2007

Volltextzugriff (PDF)

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model

Arteriosclerosis, thrombosis, and vascular biology, 2008-04, Vol.28 (4), p.665

2008

Volltextzugriff (PDF)

An Orally Active Small Molecule TGF-β Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer

Anticancer research, 2009-06, Vol.29 (6), p.2099-2109

2009

Volltextzugriff (PDF)

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Clinical cancer research, 2004-09, Vol.10 (17), p.5907-5918

2004

Volltextzugriff (PDF)

Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM

Journal of Nuclear Medicine, 2016-05, Vol.57 (5), p.812-817

2016

Volltextzugriff (PDF)

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89Zr-AMG211 Targeting CEA-Positive Tumors

Clinical cancer research, 2018-10, Vol.24 (20), p.4988-4996

2018

Volltextzugriff (PDF)

Successful shape-based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4355-4359

2003

Volltextzugriff (PDF)

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89 Zr-AMG211 Targeting CEA-Positive Tumors

Clinical cancer research, 2018-10, Vol.24 (20), p.4988

2018

Volltextzugriff (PDF)

An Orally Active Small Molecule TGF-Î² Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer

Anticancer research, 2009-06, Vol.29 (6), p.2099

2009

Volltextzugriff (PDF)

A Novel Small-Molecule Inhibitor of Transforming Growth Factor {szligbeta} Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (5), p.2351-2359

2007

Volltextzugriff (PDF)

Corrigendum to “Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)”: [Bioorg. Med. Chem. Lett. 13 (2003) 4355]

Bioorganic & medicinal chemistry letters, 2004-06, Vol.14 (11), p.2991-2991

2004

Volltextzugriff (PDF)

Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI)

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4355-4359

2003

Volltextzugriff (PDF)

The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology

Transforming Growth Factor-β in Cancer Therapy, Volume II, p.685-696

Volltextzugriff (PDF)

Su1925 - Risk of Cerebrovascular Accidents in 2143 Patients with Inflammatory Bowel Diseases: Results from a Population-Based Study

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-634-S-635

2018

Volltextzugriff (PDF)

Sa1859 - 5-Aminosalicylic Acid and Statin use are Associated with Reduced Risk of Cancers in Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S373-S373

2017

Volltextzugriff (PDF)

Transcatheter tricuspid valve edge-to-edge repair for severe tricuspid regurgitation in a Chinese patient

Heart Asia, 2018-01, Vol.10 (1), p.e010997-e010997

2018

Volltextzugriff (PDF)

5-Aminosalicylic Acid and Statin use are Associated with Reduced Risk of Cancers in Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S373-S373

2017

Volltextzugriff (PDF)

Surgical treatment of recalcitrant radiation‐induced gastric erosions

Head & neck, 2000-05, Vol.22 (3), p.303-306

2000

Volltextzugriff (PDF)

A 23-Lamp Helidon

Architectural science review, 1999-03, Vol.42 (1), p.49-53

1999

Volltextzugriff (PDF)

The upper limit of thermoelectric figure of merit: importance of electronic thermoelectric efficiency

Journal of physics. D, Applied physics, 2012-02, Vol.45 (8), p.85102-1-7

2012

Volltextzugriff (PDF)

Surgical treatment of recalcitrant radiation-induced gastric erosions

Head & Neck, 2000, Vol.22 (3), p.303-306

2000

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel small-molecule inhibitor of transforming growth factor β type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection

SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model

An Orally Active Small Molecule TGF-β Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Biodistribution and PET Imaging of Labeled Bispecific T Cell-Engaging Antibody Targeting EpCAM

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89Zr-AMG211 Targeting CEA-Positive Tumors

Successful shape-based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)

Molecular Imaging of Radiolabeled Bispecific T-Cell Engager 89 Zr-AMG211 Targeting CEA-Positive Tumors

An Orally Active Small Molecule TGF-Î² Receptor I Antagonist Inhibits the Growth of Metastatic Murine Breast Cancer

A Novel Small-Molecule Inhibitor of Transforming Growth Factor {szligbeta} Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

Corrigendum to “Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)”: [Bioorg. Med. Chem. Lett. 13 (2003) 4355]

Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI)

The Use of Virtual Screening in ALK5 Kinase Inhibitor Discovery and Validation of Orally Active ALK5 Kinase Inhibitors in Oncology

Su1925 - Risk of Cerebrovascular Accidents in 2143 Patients with Inflammatory Bowel Diseases: Results from a Population-Based Study

Sa1859 - 5-Aminosalicylic Acid and Statin use are Associated with Reduced Risk of Cancers in Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study

Transcatheter tricuspid valve edge-to-edge repair for severe tricuspid regurgitation in a Chinese patient

5-Aminosalicylic Acid and Statin use are Associated with Reduced Risk of Cancers in Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study

Surgical treatment of recalcitrant radiation‐induced gastric erosions

A 23-Lamp Helidon

The upper limit of thermoelectric figure of merit: importance of electronic thermoelectric efficiency

Surgical treatment of recalcitrant radiation-induced gastric erosions

Suchergebnisse filtern